Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease
Sign Up to like & getrecommendations! Published in 2021 at "Process Biochemistry"
DOI: 10.1016/j.procbio.2021.08.008
Abstract: Abstract Alpha synuclien (α-syn) is a protein consist of 140 amino-acid which is abundantly present in brain and associated with Parkinson diseases (PD). The physiological functions of α-syn are not clearly understood in neurochemistry. The… read more here.
Keywords: parkinson; nanotherapeutics approaches; syn; alpha synuclien ... See more keywords